Vascular Endothelial Growth Factor???Targeted Therapies in Advanced Renal Cell Carcinoma, Hematology/Oncology Clinics of North America, vol.25, issue.4, pp.813-833, 2011. ,
DOI : 10.1016/j.hoc.2011.04.006
Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor Prognosis, JNCI Journal of the National Cancer Institute, vol.87, issue.21, pp.1603-1612, 1995. ,
DOI : 10.1093/jnci/87.21.1603
Identification of a tumor-initiating stem cell population in human renal carcinomas, The FASEB Journal, vol.22, issue.10, pp.3696-3705, 2008. ,
DOI : 10.1096/fj.08-102590
Renal-Cell Carcinoma, New England Journal of Medicine, vol.353, issue.23, pp.2477-2490, 2005. ,
DOI : 10.1056/NEJMra043172
Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy, Clinical Cancer Research, vol.14, issue.7, pp.1931-1937, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-4478
Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma, BJU International, vol.80, issue.3, pp.401-404, 1997. ,
DOI : 10.1046/j.1464-410X.1997.00374.x
TGF-beta receptor signaling, Biochim Biophys Acta, vol.1333, issue.2, pp.105-150, 1997. ,
Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis, Human Pathology, vol.43, issue.7, pp.1037-1043, 2012. ,
DOI : 10.1016/j.humpath.2011.08.012
CD105 is important for angiogenesis: evidence and potential applications, The FASEB Journal, vol.17, issue.9, pp.984-992, 2003. ,
DOI : 10.1096/fj.02-0634rev
Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies, JNCI Journal of the National Cancer Institute, vol.104, issue.2, pp.93-113, 2012. ,
DOI : 10.1093/jnci/djr511
Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined Analysis, The Journal of Urology, vol.171, issue.3, pp.1071-1076, 2004. ,
DOI : 10.1097/01.ju.0000110610.61545.ae
Prognostic significance of morphologic parameters in renal cell carcinoma, The American Journal of Surgical Pathology, vol.6, issue.7, pp.655-663, 1982. ,
DOI : 10.1097/00000478-198210000-00007
Primary structure of endoglin, an RGDcontaining glycoprotein of human endothelial cells, J Biol Chem, vol.265, issue.15, pp.8361-8364, 1990. ,
Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche, Cancer Research, vol.71, issue.15, pp.71-5346, 2011. ,
DOI : 10.1158/0008-5472.CAN-11-0241
Cancer stem cells in solid tumors, Seminars in Cancer Biology, vol.20, issue.2, pp.77-84, 2010. ,
DOI : 10.1016/j.semcancer.2010.03.004
EDITORIAL. CD105 AND ANGIOGENESIS, The Journal of Pathology, vol.8, issue.4, pp.363-366, 1996. ,
DOI : 10.1002/(SICI)1096-9896(199604)178:4<363::AID-PATH491>3.0.CO;2-8
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer, International Journal of Cancer, vol.76, issue.2, pp.122-126, 2000. ,
DOI : 10.1002/(SICI)1097-0215(20000320)89:2<122::AID-IJC4>3.0.CO;2-M
PROGNOSTIC ROLE OF FUHRMAN GRADE AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN pT1a CLEAR CELL CARCINOMA IN PARTIAL NEPHRECTOMY SPECIMENS, The Journal of Urology, vol.174, issue.4, pp.1208-1212, 2005. ,
DOI : 10.1097/01.ju.0000173078.57871.2d
Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers, Pathology International, vol.14, issue.12, pp.717-723, 2006. ,
DOI : 10.1007/s00262-006-0155-5
A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer, Clinical Cancer Research, vol.18, issue.17, pp.4820-4829, 2012. ,
DOI : 10.1158/1078-0432.CCR-12-0098
Endoglin (CD105) expression in human renal cell carcinoma, BJU International, vol.80, issue.4, pp.706-710, 2006. ,
DOI : 10.1111/j.1464-410X.2004.04605.x
Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin, Clin Cancer Res, vol.3, issue.7, pp.1031-1044, 1997. ,
Metabolism of Kidney Cancer: From the Lab to Clinical Practice, European Urology, vol.63, issue.2, pp.244-251, 2013. ,
DOI : 10.1016/j.eururo.2012.09.054
Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide, Cancer Res, issue.21, pp.61-7846, 2001. ,
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation, European Journal of Cancer, vol.32, issue.14, pp.2474-2484, 1996. ,
DOI : 10.1016/S0959-8049(96)00379-6
Prognostic factors in renal cell carcinoma, World Journal of Urology, vol.27, issue.3, pp.319-327, 2010. ,
DOI : 10.1007/s00345-010-0540-8
URL : https://hal.archives-ouvertes.fr/inserm-00472418
Tumor Angiogenesis and Metastasis ??? Correlation in Invasive Breast Carcinoma, New England Journal of Medicine, vol.324, issue.1, pp.1-8, 1991. ,
DOI : 10.1056/NEJM199101033240101
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer, The Prostate, vol.97, issue.4, pp.268-275, 2002. ,
DOI : 10.1002/pros.10083
Histopathological analysis of angiogenic factors in renal cell carcinoma, International Journal of Urology, vol.5, issue.4, pp.220-227, 2003. ,
DOI : 10.1016/S0303-7207(01)00709-2